News

Filter

Current filters:

Actiq

1 to 9 of 58 results

NasalFent gives earlier pain relief than IRMS

03-06-2009

UK speciality drugmaker Archimedes Pharma released strong Phase III trial data for NasalFent, its fentanyl…

ActiqFentanyl CitrateFlunisolideMometasone FuroateNasal Spray

NasalFent gives cancer-pain relief in five min

11-05-2009

Archimedes Pharma, a UK-based specialty drug company, has presented positive data from the 043 study…

ActiqFentanyl CitrateFlunisolideMometasone FuroateNasal Spray

Archimedes' NasalFent meets Ph III efficacy endpoint

20-10-2008

UK drugmaker Archimedes Pharma has reported positive headline Phase III trial results for NasalFent,…

ActiqFentanyl CitrateFlunisolideMometasone FuroateNasal Spray

Cephalon agrees to pay $425M to resolve off-label marketing allegations

06-10-2008

The US Justice Department has announced that biopharmaceuticals firm Cephalon will enter a criminal plea…

ActiqCephalonFentanyl CitrateGabitrilModafinilNystatinOralProvigilTiagabine Hydrochloride

Archimedes licenses German rights to Molteni's Oramorph

18-08-2008

UK-based Archimedes Pharma has reached agreement with Italy's Molteni Farmaceuti to in-license commercial…

ActiqFentanyl CitrateFlunisolideMometasone FuroateNasal Spray

1 to 9 of 58 results

COMPANY SPOTLIGHT

Menarini

Back to top